Skip to main content
B

BIOMM SA — Investor Relations & Filings

SA Manufacturing
Filings indexed 229 across all filing types
Latest filing 2014-03-28 Regulatory Filings
Country BR Brazil
Listing SA

About BIOMM SA

BIOMM SA specializes in the development, manufacturing, and commercialization of complex biopharmaceuticals and biosimilar drug products. Founded as a spin-off from a major insulin producer, the company focuses on advanced treatments for chronic conditions, particularly diabetes. Its portfolio includes human and swine insulins produced via recombinant DNA techniques, alongside specialized delivery systems such as the Biopemm reusable device and Afrezza inhaled insulin. The organization operates a dedicated production facility for the manufacture of high-tech medications and maintains strategic partnerships to broaden its therapeutic reach, including the introduction of semaglutide treatments. The firm emphasizes quality and accessibility in biomedicines, leveraging technical expertise to provide innovative healthcare solutions for patients requiring specialized biological therapies.

Recent filings

Filing Released Lang Actions
DFP 2013
Regulatory Filings
2014-03-28 Portuguese
FRE 2013 v11
Regulatory Filings
2014-02-28 Portuguese
FRE 2013 v10
Regulatory Filings
2014-02-19 Portuguese
FRE 2013 v9
Regulatory Filings
2014-02-03 Portuguese
FRE 2013 v8
Regulatory Filings
2014-01-28 Portuguese
FRE 2013 v7
Regulatory Filings
2014-01-03 Portuguese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.